Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs NextEra Energy, Inc. (NEE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs NextEra Energy, Inc. — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.5 (market cap $31.07B), while NextEra Energy, Inc. trades at $78.52 (market cap $163.17B). The key difference: NextEra Energy, Inc. is far larger — about 5.3× GE HealthCare Technologies Inc. Common Stock's market cap, and NextEra Energy, Inc. pays the higher dividend (3.19%). Which is the better fit depends on your goals.
| GEHC | NEE | |
|---|---|---|
Market Cap | $31.07B | $163.17B |
Volume | 3,443,020 | 9,492,162 |
Sector | Health | Utilities |
52-Week High | $88.16 | $97.88 |
52-Week Low | $59.48 | $75.49 |
Enterprise Value | $39.53B | $270.50B |
Dividend Yield | 0.23% | 3.19% |
Typical Hold Time | — | 83 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
NextEra Energy (NEE) trades at $78.37, down 0.18% today, with a bullish technical signal but mixed indicators. The company reported strong earnings beats in Q1 and Q2 2026, with revenue growth and a net income margin of 32.4%. Recent news highlights expansion in gas generation and a major infrastructure partnership. Analyst consensus is strongly bullish with a $96 price target, though the stock is near a 52-week low of $74.78, indicating potential value.
Outlook is positive due to robust fundamentals and growth initiatives, but risks include rising debt levels and interest rate sensitivity. The stock offers a dividend yield with upcoming payment, supporting income investors. Upside potential exists if earnings momentum continues, but macroeconomic headwinds and competitive pressures warrant caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About NextEra Energy, Inc.
NextEra Energy's regulated utility, Florida Power & Light, distributes power to more than 5 million customers in Florida. FP&L contributes more than 60% of the group's operating earnings. The renewable energy segment generates and sells power throughout the United States and Canada. Consolidated generation capacity totals more than 50 gigawatts and includes natural gas, nuclear, wind, and solar assets.
Read more on NEE →
